News Focus
News Focus
icon url

tdbowieknife

05/05/26 10:14 PM

#54079 RE: BigBadWolf #54078

The whole Texatron thing is ridiculous... Absolutely NOTHING to back any of their claims up. The claims don't even make any sense regarding the understanding of fusion physics, or does the business tack they have taken to finance this "miracle machine"... What makes sense is that it's a complete fraud to sell worthless stock.


.


.

Watch your wallet


Buyer Beware
Social Media Promoted Frontload Pump and Dump Share Selling Scam



..


.
icon url

BigBadWolf

05/06/26 9:33 AM

#54089 RE: BigBadWolf #54078

$AMFN’s own words SUMMARY OF SIGNIFICANT RISKS

An investment in our common stock involves substantial risks. The most significant risks include: our pre-revenue, development-stage status with no operating history in fusion energy; the unproven nature of the Texatron™ platform and risk that we may never achieve net-positive energy or commercial viability; substantial capital requirements and potential going concern issues; extensive regulatory hurdles (DOE, NRC, EPA); intense competition in the fusion sector; and risks related to our common stock (e.g., volatility, limited liquidity on OTC Markets). See “Item 1A. Risk Factors” for a more detailed discussion of these and other risks.

We are a development-stage company with a history of losses and no revenue, and we may never achieve profitability.

We are a pre-revenue, development-stage company focused on fusion energy technology. Since our inception in 1947, we have undergone multiple business transformations, including periods of limited operations and reporting suspensions. The Company reported net losses of $255,333 and $773,994 for the years ended December 31, 2025 and 2024, respectively. As of December 31, 2025 and 2024, the Company had accumulated deficits of $20,356,048 and $20,100,715, respectively. Our operations have been funded primarily through equity issuances and related-party loans, and we have no history of generating revenue from our Texatron™ platform or any other product. We expect to continue incurring significant losses as we advance R&D, prototype testing, and commercialization efforts. If we fail to achieve technological milestones, such as demonstrating a 100 MW Texatron™ system by the end of 2026, or secure additional financing (including our planned $50 million raise in 2026), we may be unable to continue as a going concern. Our independent auditors may issue a qualified opinion on our financial statements if substantial doubt exists about our ability to continue operations.

Our fusion technology is unproven and may never achieve commercial viability.

The Texatron™ platform relies on pulsed magneto-inertial fusion using aneutronic fuels like deuterium-helium-3 (D–He³), which requires higher plasma temperatures than traditional deuterium-tritium systems. We have not yet achieved net-positive energy fusion, sustained reactions, or grid-scale power generation. Proof-of-principle experiments, such as our Version 9 prototype in Midland, Texas, have demonstrated stable plasma formation at sub-fusion temperatures, but scaling to fusion-relevant conditions involves significant uncertainties, including plasma instability, MHD disruptions, material degradation from charged particles, and efficient direct energy conversion. If we cannot overcome these technical challenges, our technology may fail, rendering our IP and investments worthless.

We depend on successful R&D and prototype testing, which are inherently uncertain and costly.

Our success hinges on advancing the Texatron™ through milestones like third-party IP valuation, audited financials, and a 100 MW demonstration by end-2026. R&D expenses are expected to increase substantially, and unforeseen issues (e.g., component failures, data anomalies, or safety incidents) could delay progress. We have limited resources and may not attract or retain specialized talent in plasma physics, materials science, or engineering. Past experiments validate core concepts, but full-scale testing may reveal flaws, leading to redesigns, cost overruns, or abandonment.

Our aneutronic fusion approach involves unique risks, including fuel supply challenges.

While D–He³ fusion offers benefits like reduced neutron damage and minimal waste, it requires rare helium-3, which is scarce on Earth and primarily sourced from lunar regolith or tritium decay. Supply disruptions, geopolitical issues, or price volatility could hinder development. Alternative fuels may not perform as expected, and our direct energy conversion methods remain experimental, potentially resulting in lower efficiency or system failures.

Our pulsed operation model may introduce additional engineering complexities and failure modes.

The Texatron™'s cyclic pulsed design, involving rapid compression and dissipation, could lead to fatigue in magnetic coils, vacuum systems, or structural components over repeated cycles. Unanticipated wear or synchronization errors in pulse timing may cause system failures, increasing maintenance costs and delaying commercialization.

We may not achieve the projected efficiencies or cost reductions from our modular design.

Our Texatron™ is designed for modular scaling (1 MW to 500 MW), but manufacturing complexities, integration issues, or unforeseen economies of scale limitations could result in higher-than-expected costs per unit. If modular deployment does not yield the anticipated reductions in construction time or expenses, our Power-as-a-Service model may not be competitive.

Our IP development timeline may not be achieved, exposing us to competitive risks.

We plan to file at least 250 additional patent applications by the end of 2026, but delays in drafting, prosecution, or approvals could leave our technology unprotected. If competitors file similar patents first or challenge ours, we may lose market advantage or face infringement claims.

We depend on third-party validations and partnerships for key milestones.

Our development timeline includes third-party valuation of our intellectual property and potential collaborations (e.g., for data center pilots or university research). If these validations are unfavorable or partnerships fail to materialize, it could delay financing, erode investor confidence, or require us to seek alternatives at higher cost.

Our reliance on aneutronic fusion may limit our ability to achieve net-positive energy in the near term.

Aneutronic D–He³ fusion requires significantly higher plasma temperatures and densities than deuterium-tritium systems, which have themselves not yet achieved sustained net-positive energy at scale. If we cannot reach these conditions efficiently within our pulsed architecture, our timeline for commercialization could be substantially delayed or our technology may prove commercially unviable.

We may experience material delays or failures in prototype scaling and testing.

Our current Version 9 prototype testing in Midland, Texas, is at sub-fusion temperatures. Scaling to higher power outputs (e.g., 100 MW demonstration by end-2026) involves increased magnetic field strengths, energy inputs, and material stresses that could reveal unforeseen instabilities, component failures, or safety issues, requiring iterative redesigns and additional capital.

Our direct energy conversion technology is experimental and may not achieve expected efficiencies.

While charged particle output from aneutronic reactions theoretically enables direct electrical generation without thermal cycles, practical implementation (e.g., magnetic field pressure capture) remains unproven at scale. Lower-than-expected conversion efficiency could make our systems uneconomic compared to conventional generation.

We face risks associated with fuel sourcing and availability.

Helium-3 is extremely rare on Earth and expensive to produce or extract. Any disruption in supply (e.g., from tritium decay sources or future lunar mining concepts) or significant price increases could impair our ability to conduct experiments or deploy systems, forcing reliance on alternative fuels with inferior characteristics.

Safety incidents involving our prototypes could result in significant liability or reputational harm.

High-energy plasma, strong magnetic fields, and pulsed power systems pose risks of electrical hazards, implosions, or radiation exposure (even if minimal in aneutronic systems). Any incident could lead to injuries, regulatory shutdowns, litigation, or negative publicity, delaying development and harming investor confidence.

We may not achieve the anticipated benefits of direct energy conversion.

Our reliance on charged particle output for direct electrical generation is experimental and may yield lower efficiencies than projected due to magnetic field losses or particle scattering. If thermal cycles become necessary as a fallback, this could increase system complexity, costs, and environmental footprint, undermining our competitive advantage.

Regulatory and Environmental Risks

We are subject to extensive government regulations, and failure to obtain approvals could prevent commercialization.

Fusion development requires approvals from the U.S. Department of Energy (DOE), Nuclear Regulatory Commission (NRC), and Environmental Protection Agency (EPA), including export controls under the Atomic Energy Act. Our Texatron™ may need NRC licensing for demonstration plants, environmental impact assessments, and compliance with IAEA standards for international expansion. Regulatory processes are lengthy (potentially years), uncertain, and evolving—changes in fusion guidelines or policy (e.g., under the ADVANCE Act) could delay us. Non-compliance risks fines, shutdowns, or bans.

Environmental, health, and safety risks could impact operations and public perception.

Although aneutronic fusion produces minimal radiation, our prototypes involve high-energy plasma and magnetic fields, posing risks of electromagnetic interference, material failures, or accidents. Public opposition to nuclear technologies (including fusion) could lead to protests, litigation, or permitting denials. Climate-related regulations (e.g., IRA incentives) may benefit us but could change unfavorably.

Fusion-specific regulatory frameworks are evolving and uncertain.

The NRC and DOE have limited precedent for regulating commercial fusion (as opposed to fission). Emerging guidelines (e.g., under the ADVANCE Act or DOE fusion programs) could impose unexpected requirements, timelines, or costs. Changes in federal fusion policy or funding priorities could adversely affect us.

We may be subject to export control and national security restrictions.

Our technology involves sensitive plasma physics and magnetic confinement know-how that may be classified as dual-use or subject to ITAR/EAR export controls. Restrictions on international collaboration, sales, or technology transfer could limit our global deployment strategy.

Environmental permitting and public opposition could delay or prevent deployments.

Even with low radiation output, siting Texatron™ units near customers (e.g., data centers) may require environmental impact statements under NEPA. Public or community opposition to fusion (due to nuclear associations) could result in local zoning denials or delays.


After today & w/ the company’s own words above I am going to try & refrain a bit until my CPA/MBA analysis of the Form 10 followed by May 15, 2026 & the subsequent Q I will however counter any unfounded hype & further pump BS w/ further verified scientific data.